Abbott Board Seeks To Nix Suit From Spinoff's Shareholders
Abbott Laboratories directors urged a Delaware Chancery judge Monday to toss a derivative suit that calls for them to bear defense costs for a whistleblower action faced by former subsidiary AbbVie...To view the full article, register now.
Already a subscriber? Click here to view full article